CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

BioMarin Targets Amicus Synergies as VOXZOGO Nears $1B Milestone

VOXZOGOPositive
AI Analysis

Summary

BioMarin is targeting synergies with Amicus Therapeutics while VOXZOGO approaches a $1 billion revenue milestone, indicating strong commercial performance of the drug.

Financial Highlights

Revenue

approaching $1B

Importance:6/10
Sentiment:
0.50
acquisitioncommercial_milestonerevenue
Related Companies

Read the original article

Published by yahoo_finance on September 18, 2026 5:02 PM

Read Original